A detailed history of Assenagon Asset Management S.A. transactions in Neuronetics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 125,974 shares of STIM stock, worth $100,779. This represents 0.0% of its overall portfolio holdings.

Number of Shares
125,974
Previous 135,746 7.2%
Holding current value
$100,779
Previous $244,000 61.07%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$0.73 - $2.0 $7,133 - $19,544
-9,772 Reduced 7.2%
125,974 $95,000
Q2 2024

Jul 18, 2024

BUY
$1.73 - $4.81 $90,738 - $252,284
52,450 Added 62.97%
135,746 $244,000
Q1 2024

Apr 24, 2024

SELL
$2.68 - $4.8 $7,680 - $13,756
-2,866 Reduced 3.33%
83,296 $396,000
Q4 2023

Jan 17, 2024

SELL
$1.05 - $2.9 $183,199 - $505,980
-174,476 Reduced 66.94%
86,162 $249,000
Q3 2023

Nov 06, 2023

SELL
$1.29 - $2.22 $1,548 - $2,664
-1,200 Reduced 0.46%
260,638 $351,000
Q3 2022

Oct 27, 2022

BUY
$2.35 - $4.66 $615,319 - $1.22 Million
261,838 New
261,838 $833,000
Q2 2022

Jul 27, 2022

SELL
$2.09 - $3.71 $39,292 - $69,748
-18,800 Closed
0 $0
Q1 2022

Apr 25, 2022

BUY
$2.84 - $4.52 $53,392 - $84,975
18,800 New
18,800 $57,000
Q4 2021

Feb 01, 2022

SELL
$3.87 - $6.59 $338,257 - $575,998
-87,405 Closed
0 $0
Q3 2021

Oct 19, 2021

SELL
$6.22 - $15.54 $1.23 Million - $3.08 Million
-198,459 Reduced 69.42%
87,405 $573,000
Q2 2021

Jul 15, 2021

BUY
$10.15 - $17.25 $2.9 Million - $4.93 Million
285,864 New
285,864 $4.58 Million

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $21.6M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.